Ionis Pharmaceuticals, Inc.
IONSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
705
Cost of Revenue
11
Gross Profit
694
Gross Margin
98.4%
Operating Income
-475
Operating Margin
-67.4%
Net Income
-454
Net Margin
-64.4%
EPS (Basic)
$-3.04
EPS (Diluted)
$-3.04
EBITDA
-354
EBITDA Margin
-50.2%
2023
12/31/2023
Revenue
788
Cost of Revenue
9
Gross Profit
779
Gross Margin
98.8%
Operating Income
-354
Operating Margin
-44.9%
Net Income
-366
Net Margin
-46.5%
EPS (Basic)
$-2.56
EPS (Diluted)
$-2.56
EBITDA
-236
EBITDA Margin
-29.9%
2022
12/31/2022
Revenue
587
Cost of Revenue
14
Gross Profit
573
Gross Margin
97.6%
Operating Income
-410
Operating Margin
-69.8%
Net Income
-270
Net Margin
-45.9%
EPS (Basic)
$-1.90
EPS (Diluted)
$-1.90
EBITDA
-228
EBITDA Margin
-38.8%
2021
12/31/2021
Revenue
810
Cost of Revenue
11
Gross Profit
800
Gross Margin
98.7%
Operating Income
-30
Operating Margin
-3.7%
Net Income
-29
Net Margin
-3.5%
EPS (Basic)
$-0.20
EPS (Diluted)
$-0.20
EBITDA
-5
EBITDA Margin
-0.6%
2020
12/31/2020
Revenue
729
Cost of Revenue
12
Gross Profit
717
Gross Margin
98.4%
Operating Income
-172
Operating Margin
-23.6%
Net Income
-444
Net Margin
-60.9%
EPS (Basic)
$-3.18
EPS (Diluted)
$-3.18
EBITDA
-111
EBITDA Margin
-15.2%